Steward Partners Investment Advisory, LLC Crispr Therapeutics Ag Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 1,440 shares of CRSP stock, worth $52,257. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,440
Previous 861
67.25%
Holding current value
$52,257
Previous $33,000
48.48%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$369 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$220 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$138 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$101 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$92.2 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.83B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....